Logo image
Sign in
PRO: Patients With Recurrent Ovarian Cancer Should be Treated With Antiangiogenic Agents in Combination With Chemotherapy
Journal article

PRO: Patients With Recurrent Ovarian Cancer Should be Treated With Antiangiogenic Agents in Combination With Chemotherapy

David Boruta, John Farley and Michael J. Birrer
Clinical ovarian cancer and other gynecologic malignancies, Vol.4(2), pp.70-73
12/2011

Metrics

1 Record Views

Details